Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma
References
- Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. <em>Bull World Health Organ</em> 2011; <bold>89</bold>: 716-24. <pub-id pub-id-type="doi"><a href="https://doi.org/10.2471/BLT.11.086678" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2471/BLT.11.086678</a></pub-id>
- <em>Cancer in Slovenia 2014</em>. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2017.
- Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. <em>Cell</em> 2010; <bold>141</bold>: 52–67. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.cell.2010.03.015" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.cell.2010.03.015</a></pub-id>
- Rawlings ND, Barrett AJ. Evolutionary families of metallopeptidases. <em>Methods Enzymol</em> 1995; <bold>248</bold>: 183-228.
- Mineo TC, Ambrogi V. Malignant pleural mesothelioma: factors influencing the prognosis. <em>Oncology (Williston Park)</em> 2012; <bold>26</bold>: 1164-75.
- Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. <em>Ann Surg Oncol</em> 2006; <bold>13</bold>: 229-37. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1245/ASO.2006.03.045" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/ASO.2006.03.045</a></pub-id>
- Štrbac D, Goričar K, Dolžan V, Kovač V. Matrix metalloproteinases polymorphisms as prognostic biomarkers in malignant pleural mesothelioma. <em>Dis Markers</em> 2017; <bold>2017</bold>: 8069529. Epub 2017 Sep 12. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1155/2017/8069529" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1155/2017/8069529</a></pub-id>.
- Nan H, Niu T, Hunter DJ, Han J. Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. <em>Cancer Epidemiol Biomarkers Prev</em> 2008; <bold>17</bold>: 3551-7. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1158/1055-9965.EPI-08-0606" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1158/1055-9965.EPI-08-0606</a></pub-id>
- Lin CM, Zeng YL, Xiao M, Mei XQ, Shen LY, Guo MX, et al. The relationship between <em>MMP2</em> -1306C>T and <em>MMP9</em> -1562C>T polymorphisms and the risk and prognosis of T-cell acute lymphoblastic leukemia in a Chinese population. <em>Cell Physiol Biochem</em> 2017; <bold>42</bold>: 1458-68. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1159/000479210" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1159/000479210</a></pub-id>
- Kovač V, Zwitter M, <bold>Štrbac</bold> D, Goričar K, Rozman A, Kern I, Rajer M. Cisplatin with pemetrexed or gemcitabine in prolonged infusion for inoperable mesothelioma: a phase II randomized trial. [Abstract]. 17<sup>th</sup> World Conference on Lung Cancer, 4-7 December 2016, Vienna, Austria. <em>J Thorac Oncol</em> 2017; <bold>12(Suppl 1)</bold>: S715.
- National Institute of Environmental health Sciences. SNP Function Prediction (Func Pred). [Internet]. Available at <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html">https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html</ext-link>. Accessed 15 Jan 2017.
- Wang J, Cai Y. Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis. <em>Tumour Biol</em> 2012; <bold>33</bold>: 1819-28. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s13277-012-0441-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s13277-012-0441-0</a></pub-id>
- Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, et al. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. <em>Gene</em> 2013; <bold>517</bold>: 65-71. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.gene.2012.12.085" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.gene.2012.12.085</a></pub-id>
- Tao L, Li Z, Lin L, Lei Y, Hongyuan Y, Hongwei J, et al. MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis. <em>Genet Test Mol Biomarkers</em> 2015; <bold>19</bold>: 548-55. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1089/gtmb.2015.0123" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1089/gtmb.2015.0123</a></pub-id>
- Wieczorek E, Reszka E, Jablonowski Z, Jablonska E, Beata Krol M, Grzegorczyk A, et al. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility. <em>BJU Int</em> 2013; <bold>112</bold>: 1207-14. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/bju.12230" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/bju.12230</a></pub-id>
- Sherry ST, Ward MH, M. Kholodov, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. <em>Nucleic Acids Res</em> 2001; <bold>29</bold>: 308-11.
- Tunesi S, Ferrante D, Mirabelli D, Andorno S, Betti M, Fiorito G, et al. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility. <em>Carcinogenesis</em> 2015; <bold>36</bold>: 1129-35. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/carcin/bgv097" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/carcin/bgv097</a></pub-id>
- Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. The influence of genetic variability on the risk of developing malignant mesothelioma. <em>Radiol Oncol</em> 2018; <bold>52</bold>: 105-111. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1515/raon-2018-0004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1515/raon-2018-0004</a></pub-id>
- Neri M, Filiberti R, Taioli E, Garte S, Paracchini V, Bolognesi C, et al. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. <em>Mutat Res</em> 2005; <bold>592</bold>: 36-44. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.mrfmmm.2005.06.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.mrfmmm.2005.06.003</a></pub-id>
- Franko A, Dolžan V, Arnerić N, Dodič-Fikfak M. The influence of gene-gene and gene-environment interactions on the risk of asbestosis. <em>Biomed Res Int</em> 2013; <bold>2013</bold>: 405743. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1155/2013/405743" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1155/2013/405743</a></pub-id>
Language: English
Page range: 160 - 166
Submitted on: Dec 10, 2017
Accepted on: Dec 17, 2017
Published on: Feb 7, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2018 Danijela Strbac, Katja Goricar, Vita Dolzan, Viljem Kovac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.